Large-scale testing (Phase 3)Study completedNCT00552279
What this trial is testing
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age
Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 805